$KERX: I spoke w/ bull & bearabout Zerenex NCE "controversy" -- both thought issue was overblown, not likely to be a problem.— Adam Feuerstein (@adamfeuerstein) February 1, 2013-- Reported by Adam Feuerstein in Boston. Follow @AdamFeuerstein
Oil prices are tumbling down. Bad news for companies and petro states, but great news at the pump and for these ten industries...
Shares of late-stage biopharma Cytokinetics increased following positive comments from an Needham analyst.
Shares of Omeros fell almost 10% after analysts' downgraded the biotech.